{"id":1181,"date":"2026-08-30T23:43:08","date_gmt":"2026-08-30T23:43:08","guid":{"rendered":"https:\/\/vistaralabs.ca\/semax-peptide-research\/"},"modified":"2026-09-02T03:25:06","modified_gmt":"2026-09-02T03:25:06","slug":"semax-peptide-research","status":"publish","type":"post","link":"https:\/\/vistaralabs.ca\/fr\/semax-peptide-research\/","title":{"rendered":"Le peptide Semax : ce que la recherche couvre r\u00e9ellement"},"content":{"rendered":"<p><strong><a href=\"https:\/\/vistaralabs.ca\/buy-semax-canada\/\">Semax<\/a> is not an obscure compound everywhere in the world.<\/strong> In Russia it is a registered pharmaceutical with a nasal formulation, listed among the country&#8217;s essential medicines and in clinical use since the 1990s. Almost nowhere else has assessed it at all. Both halves of that sentence matter, and most writing about Semax keeps only the half that suits it.<\/p>\n<h2>What Semax is<\/h2>\n<p>Semax is a short synthetic peptide \u2014 seven amino acids. It was built from a fragment of <strong>ACTH<\/strong>, the adrenocorticotropic hormone, specifically the 4\u201310 region, with a short Pro-Gly-Pro tail attached to the end.<\/p>\n<p>That tail is the interesting part of the design. ACTH is a hormone with powerful effects on the adrenal system, and the researchers who developed Semax wanted the fragment&#8217;s activity in the brain without the hormonal activity in the body. Adding the Pro-Gly-Pro sequence did two things at once: it made the peptide far more stable against the enzymes that would otherwise chop it up in minutes, and it removed the corticotropic hormone action of the parent molecule.<\/p>\n<p>So Semax is a deliberately engineered fragment. It is not a naturally occurring peptide and it is not ACTH.<\/p>\n<h2>Where the research points<\/h2>\n<p>The literature clusters around a few themes. In plain terms:<\/p>\n<ul>\n<li><strong>BDNF and neurotrophic signalling.<\/strong> The most consistent finding across the published work is that Semax is associated with increased expression of brain-derived neurotrophic factor and its TrkB receptor. BDNF is the protein most often studied in connection with synaptic plasticity \u2014 the brain&#8217;s capacity to form and reshape connections.<\/li>\n<li><strong>Neuroprotection models.<\/strong> The original Russian programme was aimed at ischaemic stroke and brain injury, and a substantial share of the clinical work sits there rather than in healthy cognition.<\/li>\n<li><strong>Attention and memory models.<\/strong> The cognitive strand \u2014 the one that gave Semax its nootropic reputation \u2014 is real but smaller than the neuroprotection work behind it.<\/li>\n<li><strong>Melanocortin activity.<\/strong> As an ACTH-derived sequence, Semax retains activity at melanocortin receptors, which is one proposed route for its effects on attention and arousal.<\/li>\n<\/ul>\n<h2>The honest state of the evidence<\/h2>\n<p>This is where most Semax writing goes quiet, so it is worth being direct.<\/p>\n<p><strong>The clinical literature is almost entirely Russian.<\/strong> Semax went through the Russian regulatory system in the early 1990s and has been in use there since. That is a genuinely longer clinical history than nearly anything else in the research-peptide category \u2014 few compounds in this space carry anything comparable.<\/p>\n<p>But a Russian registration is not an FDA or Health Canada assessment. Much of the supporting work is published in Russian, in journals with limited international reach, and the trials are generally small by Western standards. Independent replication outside Russia is thin.<\/p>\n<div class=\"vl-note\">\n<p>The fair summary: Semax has more human clinical history than most research peptides and less independent verification than any approved Western drug. Anyone telling you it is <em>proven<\/em>, and anyone telling you it is <em>baseless<\/em>, is overstating their case in one direction or the other.<\/p>\n<\/div>\n<h2>Why it is usually studied intranasally<\/h2>\n<p>The registered Russian product is a nasal solution, and the published work follows that route. There is a mechanistic reason: peptides are large, charged molecules that cross the blood\u2013brain barrier poorly, and the nasal route is studied as a way of reaching the central nervous system more directly along the olfactory pathway. For a compound whose entire point of interest is in the brain, that route choice drives a lot of the literature.<\/p>\n<p>This is covered in more depth in our comparison of intranasal versus subcutaneous research routes.<\/p>\n<h2>Semax and Selank<\/h2>\n<p>The two come from the same Russian research lineage and are frequently studied as a pair, which is why they are so often discussed together. They are not variants of each other \u2014 Semax is derived from ACTH and is the stimulating, plasticity-oriented half, while <a href=\"https:\/\/vistaralabs.ca\/selank-peptide-research\/\">Selank<\/a> derives from tuftsin and sits on the calming, GABAergic side. Our <a href=\"https:\/\/vistaralabs.ca\/semax-vs-selank\/\">Semax vs Selank comparison<\/a> covers what actually separates them.<\/p>\n<h2>What Semax is not<\/h2>\n<ul>\n<li><strong>Not a stimulant.<\/strong> It has no amphetamine-class mechanism and does not act on the dopamine transporter the way that category does.<\/li>\n<li><strong>Not a growth or metabolic peptide.<\/strong> It has nothing to do with the GH axis or the incretin receptors that define the <a href=\"https:\/\/vistaralabs.ca\/peptides-for-weight-loss\/\">weight-loss peptide<\/a> category.<\/li>\n<li><strong>Not approved in Canada.<\/strong> Health Canada has not assessed Semax for safety or efficacy, and it holds no Canadian marketing authorisation.<\/li>\n<\/ul>\n<div class=\"vl-note\">\n<p>Vistara Labs stocks <a href=\"https:\/\/vistaralabs.ca\/semax-10mg\/\">Semax 10&nbsp;mg<\/a> as a lyophilised powder, shipped from within Canada to every province, with a certificate of analysis available on request. It is also available paired with <a href=\"https:\/\/vistaralabs.ca\/buy-selank-canada\/\">Selank<\/a> and <a href=\"https:\/\/vistaralabs.ca\/buy-cerebrolysin-canada\/\">Cerebrolysin<\/a> in our <a href=\"https:\/\/vistaralabs.ca\/stacks\/\">research stacks<\/a>.<\/p>\n<\/div>\n<h2>Frequently asked questions<\/h2>\n<h3>What is Semax?<\/h3>\n<p>A seven amino acid synthetic peptide derived from the ACTH(4\u201310) fragment with a Pro-Gly-Pro tail added for stability. The modification also removes the hormonal activity of the parent molecule.<\/p>\n<h3>Is Semax approved anywhere?<\/h3>\n<p>It is a registered pharmaceutical in Russia and appears on that country&#8217;s essential medicines list, primarily for ischaemic stroke and cognitive disorders. It is not approved in Canada, the United States or the European Union.<\/p>\n<h3>What does the Semax research actually cover?<\/h3>\n<p>Mainly BDNF and neurotrophic signalling, neuroprotection in stroke and brain-injury models, and a smaller body of work on attention and memory. Most of the clinical literature is Russian and small in scale.<\/p>\n<h3>Why is Semax studied as a nasal formulation?<\/h3>\n<p>Because peptides cross the blood\u2013brain barrier poorly, and the intranasal route is studied as a more direct path to the central nervous system. The registered Russian product is a nasal solution, so the published literature largely follows that route.<\/p>\n<h3>What is the difference between Semax and Selank?<\/h3>\n<p>Semax comes from ACTH and is associated with plasticity and attention; Selank comes from tuftsin and is associated with GABAergic and anxiolytic activity. They share a research lineage but act on different systems.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is Semax?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"A seven amino acid synthetic peptide derived from the ACTH(4-10) fragment with a Pro-Gly-Pro tail added for stability. The modification also removes the hormonal activity of the parent molecule.\"}},{\"@type\":\"Question\",\"name\":\"Is Semax approved anywhere?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It is a registered pharmaceutical in Russia and appears on that country's essential medicines list, primarily for ischaemic stroke and cognitive disorders. It is not approved in Canada, the United States or the European Union.\"}},{\"@type\":\"Question\",\"name\":\"What does the Semax research actually cover?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Mainly BDNF and neurotrophic signalling, neuroprotection in stroke and brain-injury models, and a smaller body of work on attention and memory. Most of the clinical literature is Russian and small in scale.\"}},{\"@type\":\"Question\",\"name\":\"Why is Semax studied as a nasal formulation?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Because peptides cross the blood-brain barrier poorly, and the intranasal route is studied as a more direct path to the central nervous system. The registered Russian product is a nasal solution, so the published literature largely follows that route.\"}},{\"@type\":\"Question\",\"name\":\"What is the difference between Semax and Selank?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Semax comes from ACTH and is associated with plasticity and attention; Selank comes from tuftsin and is associated with GABAergic and anxiolytic activity. They share a research lineage but act on different systems.\"}}]}<\/script><\/p>\n<div class=\"vl-ruo\">\n<p>All products supplied by Vistara Labs are intended for laboratory research use only. They are not drugs, are not approved for human or veterinary use, and are not intended to diagnose, treat, cure or prevent any condition. Nothing on this page constitutes medical advice or guidance for use in humans.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Le Semax est un m\u00e9dicament homologu\u00e9 en Russie et non approuv\u00e9 presque partout ailleurs. Ce que la recherche couvre, o\u00f9 les donn\u00e9es sont minces, et comment il est fourni au Canada.<\/p>","protected":false},"author":1,"featured_media":1281,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","_vistara_fr_title":"","_vistara_fr_desc":"","_vl_research_product":52,"footnotes":""},"categories":[33],"tags":[],"vl_research_area":[39],"class_list":["post-1181","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-peptide-research"],"_links":{"self":[{"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/posts\/1181","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/comments?post=1181"}],"version-history":[{"count":2,"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/posts\/1181\/revisions"}],"predecessor-version":[{"id":1233,"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/posts\/1181\/revisions\/1233"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/media\/1281"}],"wp:attachment":[{"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/media?parent=1181"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/categories?post=1181"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/tags?post=1181"},{"taxonomy":"vl_research_area","embeddable":true,"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/vl_research_area?post=1181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}